Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cue Biopharma (CUE) Other Accumulated Expenses (2017 - 2018)

Cue Biopharma (CUE) has disclosed Other Accumulated Expenses for 2 consecutive years, with $79188.0 as the latest value for Q4 2018.

  • Quarterly Other Accumulated Expenses fell 19.08% to $79188.0 in Q4 2018 from the year-ago period, while the trailing twelve-month figure was $79188.0 through Dec 2018, down 19.08% year-over-year, with the annual reading at $79188.0 for FY2018, 19.08% down from the prior year.
  • Other Accumulated Expenses hit $79188.0 in Q4 2018 for Cue Biopharma, down from $97857.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $97857.0 in Q4 2017 to a low of $79188.0 in Q4 2018.